Viatris
  • About Us
    • Our Story
    • Our Leadership
    • Our Culture
    • CSR
    • Global Healthcare Gateway
    • Public Policy
    • Document Library
    • Contact us
  • Products
    • Product Details
  • Newsroom
    • Australia News
    • Global Press Releases
    • Stories and Viewpoints
  • Careers
    • Working at Viatris
    • Diversity and Inclusion
    • Career FAQ
  • Investors
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Shareholder Toolkit
    • Investor FAQs
Show Menu
Change LocationAU
Choose Your Location
Global Visit our Corporate site
  • Australia
    • Austria
      • Belgium
        • Dutch
        • French
      • Brazil
        • Bulgaria
          • Canada
            • English
            • French
          • China
            • Croatia
              • Czech Republic
                • Denmark
                  • Estonia
                    • Finland
                      • France
                        • GermanyGermany
                          • Greece
                            • Hong Kong
                              • Hungary
                                • India
                                  • Ireland
                                    • Italy
                                      • Japan
                                        • Korea
                                          • Latvia
                                            • Lithuania
                                              • Malaysia
                                                • Mexico
                                                  • Netherlands
                                                    • New Zealand
                                                      • Norway
                                                        • Philippines
                                                          • Poland
                                                            • Portugal
                                                              • Romania
                                                                • Russia
                                                                  • Saudi Arabia
                                                                    • Arabic
                                                                    • English
                                                                  • Serbia
                                                                    • Slovakia
                                                                      • Slovenia
                                                                        • South Africa
                                                                          • Spain
                                                                            • Sweden
                                                                              • Switzerland
                                                                                • German
                                                                                • French
                                                                              • Taiwan
                                                                                • Thailand
                                                                                  • Türkiye
                                                                                    • United Kingdom
                                                                                      • United States

                                                                                          Leaving the Viatris site

                                                                                          You are now leaving the Australian Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site, and unaffiliated third party sites may also be subject to their own terms and data protection notices and practices. Third party sites may be subject to the laws, regulatory requirements, data protection requirements, and medical practices of another country. Accordingly, the information provided therein may not be suitable for use in your country.

                                                                                          Continue
                                                                                          Cancel

                                                                                          Localised information for

                                                                                          The page you are about to visit contains information about Viatris that is specific to . Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.

                                                                                          Cancel
                                                                                          Continue to country page

                                                                                          Localized information for Australia

                                                                                          The page you are about to visit contains information about Viatris that is specific to Australia. Regulatory requirements, data protection requirements and practices or medical practices may differ between countries, and therefore the information provided on this page may not be suitable for use in all countries.

                                                                                          Cancel
                                                                                          Confirm

                                                                                          Leaving this page

                                                                                          You are now leaving the Australia Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.
                                                                                          Cancel
                                                                                          Continue
                                                                                          1. ←
                                                                                          2. Newsroom
                                                                                          3. Australia News
                                                                                          4. Through collaboration Viatris Australia takes the ‘I’ out of iron deficiency

                                                                                          Through collaboration Viatris Australia takes the ‘I’ out of iron deficiency

                                                                                          A new survey shows patients strongly agree it is important to receive treatment information from their general practitioner and pharmacists to tackle their iron deficiency, a condition affecting 1.1 million Australians1,2

                                                                                          Sydney, 25 November 2022 – Across the world there is a growing number of patients who are being diagnosed with iron deficiency. In Australia over 1 million Australians are living with the condition and iron deficiency is a well-known, yet underdiagnosed and undertreated longstanding issue in women’s health, with at least 1 in 5 women under 50 having iron deficiency3. The prevalence of iron deficiency in vegans and vegetarians can be as high as 30% in adult men and women4.

                                                                                          Kristy Mitchell, an Australian mother living with iron deficiency, said: “It would take me at least three coffees to get through the day. The level of tiredness I felt was hard to describe, it made exercising difficult which I feel is crucial for your mental health. Being diagnosed with iron deficiency was a relief because it made me realise I wasn’t losing my spark, I could do something to fix this and get back to exercising and working a normal day. I was diagnosed again during my pregnancy and to support my baby and I, I took supplements throughout my pregnancy and for six months following.”

                                                                                          Like Kristy, many women living with the deficiency rely on iron supplements to meet their daily iron needs. Viatris’ recently commissioned survey of Australians who have been previously diagnosed with iron deficiency found that Australian consumers are looking to their general practitioner (GP) for information on what may be the best supplement for them, and whether it is backed by a credible source2.

                                                                                          The survey of 500 Australians previously diagnosed with iron deficiency in the last two years and recommended a therapeutic oral iron supplement showed more than two thirds (71 per cent) of these respondents agreed it is important their general practitioner provides necessary information they need on iron supplements, with 69 per cent preferring to use the iron supplement recommended by their GP.2

                                                                                          “The data further demonstrates that the role of a GP is fundamental in the treatment and prevention of iron deficiency. As GP shortages continue to rise, it has never been more important for us to offer patient education programs to raise awareness of iron deficiency. We know that iron deficiency may cause serious complications such as fatigue, headaches, restless legs syndrome, and can exacerbate symptoms for people with underlying heart problems. For women, iron deficiency in pregnancy is particularly important to identify and treat. Therefore, it’s important to have adequate patient education on the condition, as well as an increase in pharmacists’ knowledge on the right supplement for the individual,” said Dr Renee Eslick, leading specialist haematologist and founding member of the Haematology in Obstetrics and Women’s Health Collaborative.

                                                                                          As part of their continued commitment to address iron deficiency in Australia, Viatris awarded an unrestricted research grant to University of Western Australia’s Lawrence-Brown Professor of Vascular Surgery, Professor Toby Richards, for his research into a simple screening tool from The Iron Clinic that will be able to predict the likelihood for iron deficiency from a questionnaire and finger prick test. This will be a significant, innovative step forward in the screening process as current blood iron tests require formal laboratory samples. Although traditional blood tests will still be a more accurate form of testing and diagnostics, this new development may promote community-based screening as individuals can be screened without needing to visit a doctor.

                                                                                          “Viatris is committed to empowering people worldwide to live healthier at every stage of life, and improving health often begins from the inside out. This year our established women’s brand Ferro-grad C is sponsoring Wellbeing’s Women of the Year Awards to celebrate women who rise above the odds to contribute significantly and meaningfully to their community. We are proud to continue to invest in the whole patient journey, from research to patient education and support to increase access to healthcare,” said Sylvain Vigneault, Viatris Australia Country Manager.

                                                                                          To find out more on ways in which Viatris are supporting Australians living with iron deficiency, please visit the Ferro-grad C Health Hub, Viatris website and follow us on social media @Viatris.

                                                                                           

                                                                                          END

                                                                                           

                                                                                           

                                                                                          Media Contact:

                                                                                          Alicia Campagnolo
                                                                                          Communications Manager, Viatris Australia and New Zealand
                                                                                          M: 0449 902 687
                                                                                          E: alicia.campagnolo@viatris.com

                                                                                          Notes to the Editor:

                                                                                          About Viatris

                                                                                          Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognised brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.

                                                                                           

                                                                                          REFERENCES
                                                                                          1. Pasricha et al., 2010. Diagnosis and management of iron deficiency anaemia; a clinical update. MJA, 193: 525 -532.
                                                                                          2. Section V How respondents learned about iron deficiency products. Viatris. 2022. Data on file.
                                                                                          3. Ahmed F. Iron status among Australian adults: findings of a population-based study in Queensland, Australia. Asia PacJ Clin Nutri 2008;17(1):40-47
                                                                                          4. Pawlak R et al. Iron status of vegetarian adults: a review of literature. Analytic Review. 2018
                                                                                          • Viatris Privacy Notice
                                                                                          • Viatris Cookie Notice
                                                                                          • Terms of Use
                                                                                          • California Supplemental Disclosure
                                                                                          • Viatris’ Policy Statement Regarding Slavery and Human Trafficking
                                                                                          • Contact Us
                                                                                          • Viatris Privacy Notice
                                                                                          • Viatris Cookie Notice
                                                                                          • Terms of Use
                                                                                          • Contact Us
                                                                                          • California Supplemental Disclosure
                                                                                          • Viatris’ Policy Statement Regarding Slavery and Human Trafficking
                                                                                          • About Us
                                                                                          • Products
                                                                                          • Careers
                                                                                            • linkedin
                                                                                            • instagram
                                                                                            • twitter
                                                                                            • youtube

                                                                                            Visit our corporate site

                                                                                            Viatris

                                                                                            Visit Viatris Connect

                                                                                            © 2025 Viatris Inc. All Rights Reserved. VIATRIS, the Viatris Logo, GLOBAL HEALTHCARE GATEWAY,PARTNER OF CHOICE and the Global Healthcare Gateway logo are Viatris Company trademarks.